CervoMed Inc.
CRVO | NASDAQ
$2.43
+$0.02 (+0.83%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 322.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | 322.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -6.68M | -8.11M | -8.33M | -8.04M | -6.62M | -5.3M | -7.24M | -5.4M | -3M | -2.59M | -2.48M | -2.68M | -1.23M | -1.43M | -4.25M | -904.05K | -4.25M | -4.55M | -3.47M | -12.69M | -3.83M | -4.68M |
Interest Income | 104.9K | 147.39K | 240.94K | 318.79K | 368.13K | 408.99K | 532.18K | 646.17K | 678.44K | 80.63K | 118.65K | 47.67K | 17.71K | 35.4K | 172.86K | 21.52K | 55.38K | 27.81K | n/a | 50.71K | 55.23K | 40.42K |
Pretax Income | -6.57M | -7.96M | -8.09M | -7.73M | -6.26M | -4.89M | -6.71M | -4.75M | -2.32M | -2.51M | -2.36M | 2.15M | -1.43M | -534.34K | -4.08M | -882.62K | -4.19M | -4.53M | -3.47M | -12.64M | -3.78M | -4.64M |
Net Income | -6.57M | -7.96M | -8.09M | -7.73M | -6.26M | -4.89M | -6.71M | -4.75M | -2.32M | -2.51M | -2.36M | 2.15M | -1.43M | -534.34K | -4.08M | -882.62K | -4.19M | -4.53M | -3.47M | -12.2M | -3.78M | -4.64M |
Selling & General & Admin | 2.36M | 2.98M | 2.51M | 2.33M | 3.27M | 2.38M | 2.32M | 2.21M | 2.51M | 2.13M | 2.12M | 2.41M | 992.55K | 1M | 2.34M | 573.51K | 2.14M | 2.13M | 1.93M | 1.93M | 1.84M | 1.74M |
Research & Development | 4.32M | 5.14M | 5.83M | 6.04M | 5.11M | 4.84M | 7.09M | 5.13M | 3.77M | 2.81M | 2.86M | 1.79M | 1.96M | 1.83M | 1.9M | 330.54K | 2.11M | 2.43M | 1.5M | 2.11M | 1.97M | 2.92M |
Other Expenses | n/a | n/a | -8.73K | n/a | -1.76M | -1.92M | -2.16M | -1.94M | -3.29M | -2.35M | -2.49M | -1.53M | -1.72M | -1.41M | n/a | n/a | n/a | n/a | 26.11K | 8.66M | 23.76K | 24.45K |
Operating Expenses | 6.68M | 8.11M | 8.33M | 8.37M | 6.62M | 5.3M | 7.24M | 5.4M | 3M | 2.59M | 2.48M | 2.68M | 1.23M | 1.43M | 4.25M | 904.05K | 4.25M | 4.55M | 3.47M | 12.69M | 3.83M | 4.68M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.87K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 8.11M | 8.33M | 8.37M | 6.62M | 5.3M | 7.24M | 5.4M | 3M | 2.59M | 2.48M | 2.68M | 1.23M | 1.43M | 4.25M | 904.05K | 4.25M | 4.55M | 3.47M | 12.69M | 3.83M | 4.68M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -443.89K | n/a | n/a |
Shares Outstanding (Basic) | 10.24M | 9.26M | 9.25M | 9.25M | 8.95M | 8.7M | 8.7M | 8.7M | 8.7M | 6.17M | 5.68M | 3.31M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.11M |
Shares Outstanding (Diluted) | 10.24M | 9.26M | 9.25M | 9.25M | 8.95M | 8.7M | 8.7M | 8.7M | 8.7M | 6.17M | 5.68M | 3.77M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.11M |
EPS (Basic) | -0.64 | -0.86 | -0.87 | -0.84 | -0.70 | -0.56 | -0.77 | -0.55 | -0.27 | -0.41 | -0.42 | 0.65 | -1.55 | -3.01 | -3 | -1.70 | -3.08 | -3.33 | -2.56 | -8.98 | -2.78 | -4.21 |
EPS (Diluted) | -0.64 | -0.86 | -0.87 | -0.84 | -0.70 | -0.56 | -0.77 | -0.55 | -0.27 | -0.41 | -0.42 | -0.70 | -1.55 | -3.01 | -3 | -1.70 | -3.08 | -3.33 | -2.56 | -8.98 | -2.78 | -4.21 |
EBITDA | -6.68M | -7.96M | -8.09M | -7.73M | -6.26M | -4.89M | -6.71M | -4.75M | -2.32M | -2.51M | 3.16M | 2.15M | -1.43M | -534.34K | -4.08M | -882.62K | -4.19M | -4.53M | -3.44M | -4.04M | -3.75M | -4.66M |
EBIT | n/a | -7.96M | -8.09M | -7.73M | -6.26M | -4.89M | -6.71M | -4.75M | -2.32M | -2.51M | 3.16M | 2.15M | -1.43M | -534.34K | -4.08M | -882.62K | -4.19M | -4.53M | -3.47M | -4.05M | -3.78M | -4.68M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.11K | 19.1K | 23.76K | 24.45K |
Add to Watchlist
Select watchlists to add or remove CRVO